eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2020
vol. 22
 
Share:
Share:
Original paper

Glaucoma medications: issues with adherence in a tertiary hospital in Nigeria

Stella Ngozi Onwubiko
1
,
Nkiru Zuada Nwachukwu
1
,
Boniface Ikenna Eze
1

1.
Department of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria
Family Medicine & Primary Care Review 2020; 22(4): 302–306
Online publish date: 2020/12/29
Get citation
 
PlumX metrics:
 
1. Kyari F, Gudlavalleti MV, Sivsubramaniam S, et al. Prevalence of blindness and visual impairment in Nigeria: the National Blindness and Visual Impairment Study. Invest Ophthtalmol Vis Sci 2009; 50(5): 2033–2039.
2. Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmology 2015; 15(1): 111.
3. Omoti AE, Osahon AI, Waziri-Erameh MJ. Pattern of presentation of primary open angle glaucoma in Benin City Nigeria. Trop Doct 2006; 36(2): 97–100.
4. Lawan A. Pattern of presentation and outcome of surgical management of primary open angle glaucoma in Kano, Northern Nigeria. Ann Afr Med 2007; 6: 180–185.
5. Olawoye OO, Ashaye AO, Baiyeroju AM, et al. Outcomes of trabeculectomy with 5 Fluorouracil at a Nigerian Tertiary Hospital. J Ophthalmic Vis Res 2013; 8(2): 126–133.
6. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest Glaucoma trial. Arch Ophthalmol 2002; 120(10): 1268–1279.
7. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120(6): 701–713.
8. Tse AP, Shah M, Jamal N, et al. Glaucoma treatment adherence at a United Kingdom general practice. Eye 2016; 30(8): 1118–1122.
9. Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma 2012; 21(4): 234–240.
10. Stryker JO, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma 2010; 19(1): 66–72.
11. Bacon TS, Fan KC, Desai MA. Electronic medical record and glaucoma medications: connecting the medication reconciliation with adherence. Clin Ophthalmol 2016; 10: 221–225.
12. Djafari F, Lesk MR, Harasymowycz PJ, et al. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma 2009; 18(3): 238–243.
13. Olthoff CMG, Hoevenaars JGMM, Borne BW Van den, et al. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2008, doi: 10.1007/s00417-008-0944-y.
14. Sleath BL, Krishnadas R, Cho M, et al. Patient reported barriers to glaucoma access, use and adherence in southern India. Indian J Ophthalmol 2009; 57: 63–68.
15. Tamarat L, Gessesse GW, Gelaw Y. Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol 2015; 22(1): 59–63.
16. Omolase CO, Ogunleye OT, Sotiloye OA, et al. Compliance with topical glaucoma medications in Owo Nigeria. Brunei Int med J 2013; 9(3): 172–177.
17. Onakoya AO, Mbadugha CA. Self-reported adherencerates in glaucoma patients in Southwest Nigeria. J Clin Sci 2016; 13: 51–57.
18. Abdull MM, Gilbert C, McCambridge J, et al. Adapted motivational interviewing to improve the uptake of treatment for glaucoma in Nigeria: study protocol for a randomised controlled trials. Trials 2014; 15(1): 149.
19. Usifoh SF, Udezi WA, Omage JO. Prevalence of glaucoma in a Nigerian hospital. J Pharmacy Biosciences 2014; 11(1): 22–28.
Copyright: © 2020 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.